Investing.com - EDAP reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
EDAP announced earnings per share of €0.01 on revenue of €14.53M. Analysts polled by Investing.com anticipated EPS of €-0.048 on revenue of €11.47M.
EDAP shares are up 15.19% from the beginning of the year and are trading at €6.900 , down-from-52-week-high.They are outperforming the Nasdaq which is down 23.4% from the start of the year.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of €2.67 on revenue of €23.43B, compared to forecasts EPS of €2.59 on revenue of €23.62B.
Pfizer had beat expectations on Tuesday, May 3, 2022 with first quarter EPS of €1.62 on revenue of €25.66B, compared to forecast for EPS of €1.49 on revenue of €24.1B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar